UBS ETF Please confirm that you are resident in Germany to proceed.

Back

UBS ETF (IE) Factor MSCI USA Prime Value UCITS ETF (hedged to GBP) A-dis

Net asset value 11.818 GBP

Last update

05.12.2019

ISIN: IE00BXDZNH00

Asset Class:  Alternative Beta

Fact sheets & brochures

Fact Sheet

Tax values

Agreement & prospectuses

Prospectus

Supplement

Country supplement

Key Investor Information (KIID)

Fund documentation M&A - (Irl) ETF plc

VAG, GroMiKV reports

CRR Reporting September 2019

GroMiKV Reporting September 2019

Solvency II Reporting Q3 2019

VAG Reporting Q3 2019

Reports

Annual report

Annual report 2018

Semi-annual report

Semi-annual report 2019

Report Archive

Annual report 2012

Annual report 2013

Annual report 2014

Annual report 2015

Annual report 2016

Annual report 2017

CRR Reporting August 2019

CRR Reporting July 2019

CRR Reporting June 2019

CRR Reporting May 2019

CRR Reporting April 2019

CRR Reporting March 2019

CRR Reporting February 2019

CRR Reporting January 2019

CRR Reporting December 2018

CRR Reporting November 2018

CRR Reporting October 2018

GroMiKV Reporting August 2019

GroMiKV Reporting July 2019

GroMiKV Reporting June 2019

GroMiKV Reporting May 2019

GroMiKV Reporting April 2019

GroMiKV Reporting March 2019

GroMiKV Reporting February 2019

GroMiKV Reporting January 2019

GroMiKV Reporting December 2018

GroMiKV Reporting November 2018

GroMiKV Reporting October 2018

Solvency II Reporting Q2 2019

Solvency II Reporting Q1 2019

Solvency II Reporting Q4 2018

Semi-annual collateral report 2014

Semi-annual collateral report 2015

Semi-annual report 2013

Semi-annual report 2014

Semi-annual report 2015

Semi-annual report 2016

Semi-annual report 2017

Semi-annual report 2018

VAG Reporting Q2 2019

VAG Reporting Q1 2019

VAG Reporting Q4 2018

Aktiengewinne für KSt-pflichtige Anleger

General information

UBS Funds - Your funds at a glance

Other documents

UBS ETF Securities Lending Borrowers

UBS ETFs Securities Lending Report

Disclaimer

For marketing and information purposes by UBS. Representative in Germany for UBS Funds established under foreign law: UBS Europe SE, Bockenheimer Landstraße 2-4, 60306 Frankfurt am Main. Prospectuses, simplified prospectuses or key investor information, the articles of association or the management regulations as well as annual and semi-annual reports of UBS funds are available in a language required by the local applicable law free of charge upon written request from UBS Europe SE or from UBS Asset Management (Deutschland) GmbH, Bockenheimer Landstraße 2-4, DE-60306 Frankfurt am Main or can be looked up on www.ubs.com/deutschlandfonds. The MSCI indexes are the exclusive property of MSCI INC. (“MSCI”). MSCI and the MSCI index names are service mark(s) of MSCI or its affiliates and have been licensed for use for certain purposes by UBS AG (“UBS”). The financial securities referred to herein are not sponsored, endorsed, or promoted by MSCI, and MSCI bears no liability with respect to any such financial securities. The full prospectus of the UBS ETF Sicav contains a more detailed description of the limited relationship MSCI has with UBS and any related financial securities. No purchaser, seller or holder of this product, or any other person or entity, should use or refer to any MSCI trade name, trademark or service mark to sponsor, endorse, market or promote this product without first contacting MSCI to determine whether MSCI’s permission is required. Under no circumstances may any person or entity claim any affiliation with MSCI without the prior written permission of MSCI. Before investing in a product please read the latest prospectus carefully and thoroughly. The fund documentation is available free of charge in English and, where relevant, in one of the local language(s) where the fund is registered. The information and opinions contained in this document have been compiled or arrived at based upon information obtained from sources believed to be reliable and in good faith, but is not guaranteed as being accurate, nor is it a complete statement or summary of the securities, markets or developments referred to in the document. Members of the UBS Group may have a position in and may make a purchase and / or sale of any of the securities or other financial instruments mentioned in this document. Units of UBS funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors and may not be offered, sold or delivered in the United States. The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any specific recipient. The details and opinions contained in this document are provided by UBS without any guarantee or warranty and are for the recipient's personal use and information purposes only. This document may not be reproduced, redistributed or republished for any purpose without the written permission of UBS Asset Management Switzerland AG or a local affiliated company. Source for all data and charts (if not indicated otherwise): UBS Asset Management. More explanations of financial terms can be found at ubs.com/glossary © UBS 2019. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.